BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 21868561)

  • 1. Pleomorphic ductal carcinoma of the male breast: report of a rare case and review of literature.
    Caruso R; Palmeri R; Racchiusa S; Bonanno A; Lucianò R; Scardigno M; Branca G; Fedele F
    Anticancer Res; 2011 Sep; 31(9):3069-71. PubMed ID: 21868561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pleomorphic carcinoma with osteoclastic giant cells of the breast: immunohistochemical differentiation between coexisting neoplastic and reactive giant cells.
    Kurokawa K; Mouri Y; Asano A; Kamei K; Iwata Y; Isogai M; Saga S; Ichihara S
    Pathol Int; 2009 Feb; 59(2):91-7. PubMed ID: 19154262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histiocytoid carcinoma of the male breast.
    Hutchinson CB; Geradts J
    Ann Diagn Pathol; 2011 Jun; 15(3):190-3. PubMed ID: 20952293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synchronous bilateral invasive lobular breast cancer presenting as carcinomatosis in a male.
    Spencer JT; Shutter J
    Am J Surg Pathol; 2009 Mar; 33(3):470-4. PubMed ID: 19092630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alteration of cyclin D1 in Chinese patients with breast carcinoma and its correlation with Ki-67, pRb, and p53.
    Guo LL; Gao P; Wu YG; Jian WC; Hao CY; Li H; Lin XY
    Arch Med Res; 2007 Nov; 38(8):846-52. PubMed ID: 17923265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. E-cadherin expression in pleomorphic lobular carcinoma: an aid to differentiation from ductal carcinoma.
    Wahed A; Connelly J; Reese T
    Ann Diagn Pathol; 2002 Dec; 6(6):349-51. PubMed ID: 12478484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunohistochemical tumor markers in infiltrating ductal breast carcinoma].
    Gallegos M; González S; León A; Claure R; Goñi I; Andrade L; Duarte I
    Rev Med Chil; 1998 Oct; 126(10):1216-23. PubMed ID: 10030093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fine needle aspiration cytology of a male breast carcinoma exhibiting neuroendocrine differentiation. Report of a case with immunohistochemical, flow cytometric and ultrastructural analysis.
    Feczko JD; Rosales RN; Cramer HM; Goulet RJ; Tao LC
    Acta Cytol; 1995; 39(4):803-8. PubMed ID: 7631560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibromatosis of the male breast with concurrent florid-type gynecomastia: Report of a case and review of literature.
    El Demellawy D; Herath C; Khalil M; Nasr A; Moussa B
    Pathol Res Pract; 2011 May; 207(5):306-9. PubMed ID: 21511401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Male breast cancer: 6-year experience.
    La Pinta M; Fabi A; Ascarelli A; Ponzani T; Di Carlo V; Scicchitano F; Saputo S; Russillo M; Andrich R
    Minerva Chir; 2008 Apr; 63(2):71-8. PubMed ID: 18427439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. E-cadherin-negative primary small cell carcinoma of the breast. Report of a case and review of the literature.
    Bergman S; Hoda SA; Geisinger KR; Creager AJ; Trupiano JK
    Am J Clin Pathol; 2004 Jan; 121(1):117-21. PubMed ID: 14750249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncocytic carcinoma of the breast: frequency, morphology and follow-up.
    Ragazzi M; de Biase D; Betts CM; Farnedi A; Ramadan SS; Tallini G; Reis-Filho JS; Eusebi V
    Hum Pathol; 2011 Feb; 42(2):166-75. PubMed ID: 21111455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical co-expression of c-erbb-2/Neu oncoprotein, altered tumour suppressor (p53) protein, EGF-R and EMA in histological subtypes of infiltrating duct carcinoma of the breast.
    Sharma BK; Ray A; Kaur S; Gupta S
    Indian J Exp Biol; 1999 Mar; 37(3):223-7. PubMed ID: 10641149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pleomorphic ductal carcinoma of the breast with predominant micropapillary features.
    Lenicek T; Szerda F; Demirović A; Mijić A; Kruslin B; Tomas D
    Pathol Int; 2007 Oct; 57(10):694-7. PubMed ID: 17803659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ductal carcinoma in situ of the male breast presenting as adolescent unilateral gynaecomastia.
    McCoubrey G; Fiddes R; Clarke PJ; Coleman DJ
    J Plast Reconstr Aesthet Surg; 2011 Dec; 64(12):1684-6. PubMed ID: 21782537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Displaced epithelium after liposuction for gynecomastia.
    McLaughlin CS; Petrey C; Grant S; Ransdell JS; Reynolds C
    Int J Surg Pathol; 2011 Aug; 19(4):510-3. PubMed ID: 20519190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Invasive breast carcinoma arising in microglandular adenosis: a case report and review of the literature.
    Shui R; Yang W
    Breast J; 2009; 15(6):653-6. PubMed ID: 19824997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metastatic ductal eccrine adenocarcinoma masquerading as an invasive ductal carcinoma of the male breast.
    McLean SR; Shousha S; Francis N; Lim A; Eccles S; Nathan M; Brock CS; Palmieri C
    J Cutan Pathol; 2007 Dec; 34(12):934-8. PubMed ID: 18001417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Male breast cancer: a case report and review of the literature.
    Petrocca S; La Torre M; Cosenza G; Bocchetti T; Cavallini M; Di Stefano D; Sammartino F; Ziparo V
    Chir Ital; 2005; 57(3):365-71. PubMed ID: 16231827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of E-cadherin/beta-catenin complex and cyclin D1 in breast cancer.
    Lim SC; Lee MS
    Oncol Rep; 2002; 9(5):915-28. PubMed ID: 12168049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.